LC-MS/MS and GC-MS methods in propofol detection: Evaluation of the two analytical procedures.

Propofol is a short-acting hypnotic agent that is commonly used to induce and maintain anesthesia. Propofol abuse and its involvement in suicide deaths have increased in recent years, especially among healthcare personnel. An example is the suicide of a 61-year-old nurse found with a propofol drip in his left arm. We describe the postmortem concentration of propofol in various tissues (femoral and cardiac blood, bile, urine, brain, and liver) and in the drip. The toxicological analyses were performed through two analytical methods, differing in derivatization reaction and in instrumentation: silylation for gas chromatograph-mass spectrometer (GC-MS), as routinely performed in our laboratory for this kind of analyses (lower limits of quantification-LLOQ-in urine and blood: 0.3 and 5ng/ml); for liquid chromatograph-tandem mass spectrometer (LC-MS/MS) an innovative azo-coupling derivatization (LLOQ: 0.0004 and 0.1ng/ml). This latter produces an azo-derivative (molecular composition: C18H22ON2; molecular weight: 282Da) highly ionizable in electro-spray ion source, both in negative and positive ionizations. These two methods were compared to evaluate the effectiveness of this new LC-MS/MS analysis. An acidic hydrolysis (HCl 6N, 100°C, and 1h) was performed for the biological samples (1ml or 1g) irrespective of the analytical method applied. The drip content was extracted adding phosphate buffer (pH 8) and a dichloromethane/ethylacetate 8:2 (v:v) mixture. Derivatization steps were: silylation with N,O-bis(trimethylsilyl)trifluoroacetamide (BSTFA)+tetramethylammonium hydroxide (TMAH) for GC-MS; regarding LC-MS/MS, azo-coupling reaction with the aryl-diazonium salt (0-5°C, and 30min). The analyses were achieved in selected-ion monitoring for GC-MS (m/z, 235,250,73 propofol"; m/z, 252,267,27 propofol-d17) and in multiple reaction monitoring ([M-H](-): m/z 283→241,77, azo-propofol; m/z 299→251,77, azo-propofol-d17) for LC-MS/MS. Autopsy showed no significant findings. Propofol concentrations were (LC-MS/MS vs GC-MS, respectively): 15.1 vs 14.5mg/ml, drip content; 7.11 vs 6.07μg/ml, cardiac blood; 9.50 vs 7.19μg/ml, femoral blood; 0.64 vs 1.07μg/ml, bile; 0.042 vs 0.051μg/ml urine; 4.93 vs 5.89μg/g, brain; and 7.88 vs 6.80μg/g, liver. These values are comparable with the ones described in literature for death by acute propofol intoxication; the drip content is compatible with a diluted formulation of propofol available in Italy (20mg/ml injectable emulsion). The comparison shows an excellent fitting of the data (R(2): 0.9362). Toxicological results proved the cause of death as acute propofol intoxication. Furthermore, the new LC-MS/MS method showed an excellent effectiveness and reliability when compared to the routinely used GC-MS method.

[1]  L. Barvais,et al.  Lactic acidosis during propofol-remifentanil anesthesia in an adult. , 2004, Anesthesiology.

[2]  P. Marik,et al.  Propofol: therapeutic indications and side-effects. , 2004, Current pharmaceutical design.

[3]  B. Ludes,et al.  Determination of chronic abuse of the anaesthetic agents midazolam and propofol as demonstrated by hair analysis , 2002, International Journal of Legal Medicine.

[4]  G. Schelling,et al.  Formation of the N-methylpyridinium ether derivative of propofol to improve sensitivity, specificity and reproducibility of its detection in blood by liquid chromatography-mass spectrometry. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[5]  James G. Bollinger,et al.  Improved sensitivity mass spectrometric detection of eicosanoids by charge reversal derivatization. , 2010, Analytical chemistry.

[6]  Eunyoung Han,et al.  Deaths from recreational use of propofol in Korea. , 2013, Forensic science international.

[7]  Sooyeun Lee,et al.  Quantitative analysis of propofol-glucuronide in hair as a marker for propofol abuse , 2013, Analytical and Bioanalytical Chemistry.

[8]  J. Marier,et al.  Development of a rapid and sensitive LC-ESI/MS/MS assay for the quantification of propofol using a simple off-line dansyl chloride derivatization reaction to enhance signal intensity. , 2005, Journal of pharmaceutical and biomedical analysis.

[9]  A. Schmoldt,et al.  Death after excessive propofol abuse , 2001, International Journal of Legal Medicine.

[10]  A. Bienert,et al.  Long-term stability of propofol in human plasma and blood in different storage conditions. , 2005, Acta poloniae pharmaceutica.

[11]  M. Lowder Case presentation #2. , 2009 .

[12]  F. Peters,et al.  Fast, Simple, and Validated Gas Chromatographic-Mass Spectrometric Assay for Quantification of Drugs Relevant to Diagnosis of Brain Death in Human Blood Plasma Samples , 2005, Therapeutic drug monitoring.

[13]  M. Lapeyre-Mestre,et al.  Death related to a recreational abuse of propofol at therapeutic dose range. , 2006, British journal of anaesthesia.

[14]  T. Santa Derivatization reagents in liquid chromatography/electrospray ionization tandem mass spectrometry. , 2011, Biomedical chromatography : BMC.

[15]  K. Törő,et al.  Evaluation of a fatal propofol intoxication due to self administration. , 2009, Journal of forensic and legal medicine.

[16]  W. Leavens,et al.  Derivatisation for liquid chromatography/electrospray mass spectrometry: synthesis of pyridinium compounds and their amine and carboxylic acid derivatives. , 2003, Rapid Communications in Mass Spectrometry.

[17]  R. Boulieu,et al.  Detection of new propofol metabolites in human urine using gas chromatography/mass spectrometry and liquid chromatography/mass spectrometry techniques. , 2000, Rapid communications in mass spectrometry : RCM.

[18]  E. Kranioti,et al.  Lethal self administration of propofol (Diprivan). A case report and review of the literature. , 2007, Forensic science international.

[19]  R. Levy Clinical Effects and Lethal and Forensic Aspects of Propofol * , 2011, Journal of forensic sciences.

[20]  P. Marik Propofol: An Immunomodulating Agent , 2005, Pharmacotherapy.

[21]  P. Kintz,et al.  Evidence of addiction by anesthesiologists as documented by hair analysis. , 2005, Forensic science international.

[22]  B. Orser,et al.  Dystonic reaction to propofol attenuated by benztropine (cogentin). , 2002, Anesthesia and analgesia.

[23]  B. Madea,et al.  [Lethal mixed intoxication with propofol in a medical layman]. , 2006, Archiv fur Kriminologie.

[24]  J. Guitton,et al.  Quantitative measurement of propofol and in main glucuroconjugate metabolites in human plasma using solid phase extraction-liquid chromatography-tandem mass spectrometry. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[25]  Sean C. Sweetman,et al.  Martindale: The Complete Drug Reference , 1999 .

[26]  J. Zacny,et al.  Propofol at a Subanesthetic Dose May Have Abuse Potential in Healthy Volunteers , 1993, Anesthesia and analgesia.

[27]  D. Packer,et al.  Metabolic acidosis associated with propofol in the absence of other causative factors. , 2004, Anesthesiology.

[28]  M. Lapeyre-Mestre,et al.  Pharmacological and clinical evidences on the potential for abuse and dependence of propofol: a review of the literature , 2007, Fundamental & clinical pharmacology.

[29]  Jin Young Kim,et al.  Comparison of GC/MS and LC/MS methods for the analysis of propofol and its metabolites in urine. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[30]  E. Caravati,et al.  The abuse potential of propofol , 2010, Clinical toxicology.

[31]  R. Kirby,et al.  Death from propofol: accident, suicide, or murder? , 2009, Anesthesia and analgesia.

[32]  F. Busardò,et al.  Enhancing the sensitivity of the LC-MS/MS detection of propofol in urine and blood by azo-coupling derivatization , 2014, Analytical and Bioanalytical Chemistry.